Proposing a balanced budget amendment to the Constitution of the United States.

1. What happened and its current status: On July 23, 2025, Rep. Nathaniel Moran (R-TX) introduced H.J. Res. 110, a joint resolution proposing a constitutional amendment requiring that federal expenditures equal receipts within 10 years of ratification. The bill was referred to the House Committee on the Judiciary and has had no further actions. It remains an early-stage bill with a single sponsor (no co-sponsors) and no companion bill in the Senate. The 119th Congress (2025-2027) will need to pass the resolution by a two-thirds majority in both chambers, followed by ratification by 38 states — an extremely high bar. 2. The money trail — distinguishing authorization from appropriation: H.J. Res. 110 authorizes zero dollars. It is a constitutional amendment that mandates future Congresses to balance the budget. The bill does not specify which programs are cut — that would be left to future enabling legislation. The Congressional Budget Office would need to score the impact, but at this stage there is no funding mechanism, no contract authority, and no spending directives. The amendment explicitly exempts debt payments and allows two-thirds supermajorities to authorize emergency spending. This is purely a structural constraint, not a spending bill. 3. Structural winners and losers with tickers: If this amendment gained serious momentum (which it has not — single sponsor, no committee markup, no hearings), the structural losers would be: defense contractors ($LMT, , $GD) because defense is ~50% of discretionary spending; healthcare insurers (, $CVS) because Medicare/Medicaid are ~25% of mandatory spending; and large banks (, $BAC, $WFC, $C) because reduced Treasury issuance and economic contraction would pressure net interest income. There are no structural winners from a balanced budget amendment — the entire federal spending reduction reduces revenue for government-dependent sectors. The recent Presidential Memorandum (Apr 20, 2026) using the Defense Production Act for energy and petroleum infrastructure is unrelated and would likely be funded through separate emergency authorities if a balanced budget amendment were in effect, given it addresses national security concerns. 4. Real market data analysis: Current stock prices show a stark divergence. Defense stocks are declining sharply with real data confirming the trend: $LMT at $512.29 (down 16.8% in 30 days), at $175.68 (down 7.4%), $GD at $313.68 (down 9.5%). This decline is NOT driven by H.J. Res. 110 — it predates the bill and reflects separate defense spending concerns. Meanwhile, has surged 41.6% in 30 days to $366.77, $CVS is up 15.55% to $80.98 — healthcare stocks are rallying on their own fundamentals including the Apr 18 Executive Order on psychedelic therapies. Bank stocks are mixed but mostly higher (JPM +10.12%, BAC +12.11%, C +19.7%, WFC +5.58%) — none of these moves correlate with an early-stage constitutional amendment with zero legislative progress. 5. Timeline and legislative path: The bill has taken zero actions since referral on July 23, 2025. The House Judiciary Committee would need to hold hearings, mark up the bill, and report it to the full House. A two-thirds vote (290 votes in the House) is required for passage. The Senate would then need 67 votes. No hearings are scheduled, no companion bill exists in the Senate, and the 119th Congress is already in its second session. Constitutional amendments typically take years, and this one has gained no traction. The earliest real market impact would require committee action, which is not on the current calendar.